top of page

Monday Pānui 1 July 2024

In today’s Pānui

  • De-escalation Workshops

  • Continuation of zero-fees cervical screening for priority groups

  • National Cervical Screening Programme Information Update

  • Training Requirements for HPV Screen Takers

  • In case you missed it – Re-instatement of prescription co-payment from today and COVID-19 Services Eligibility, Vaccine Brands and Eligibility Changes

  • Two new practices join Auckland PHO

 

De-escalation Workshops

 

Practices have been sent an email inviting them to upcoming workshops on De-escalation Techniques designed to provide participants with practice skills for managing and defusing tense situations effectively.

 

Three options are available for city side practice staff and for practice teams on Waiheke Island and Great Barrier separate arrangements are being made.

 

  • Session dates are Monday 22 July, Tuesday 23 July and Thursday 25 July – 6pm for a 6.30pm start

  • Sessions will be at the Auckland PHO office – 210 Khyber Pass Road.

 

Please refer to the email sent today to book and for more information or contact komal@aucklandpho.co.nz

Continuation of zero-fees cervical screening for priority groups

 

Please refer to the Cx HPV Funding Continuation Notice of zero fees for cervical screening for priority groups.

National Cervical Screening Programme Information Update

 

Updates to testing after cancer – please refer to the Te Whatu Ora notice regarding HPV and cytology testing following treatment for cervical and vaginal cancer. HealthPathways will be updated to reflect this update in due course.

Training Requirements for HPV Screen Takers

 

A reminder that HPV Screen Takers must complete a learning pathway prior to facilitating HPV self-testing with participants.  If unsure, please refer to the Te Whatu Ora requirements- link below.

https://www.tewhatuora.govt.nz/health-services-and-programmes/ncsp-hpv-screening/understand-hpv-primary-screening/#hpv-screen-takers-training

 

 

In case you missed it –

There are a number of changes effective 1 July – please refer to the three Medinz messages below published Thursday 27 June:

  • Reinstatement of prescription co-payment

  • Important update on eligibility for COVID-19 Services and Funding

  • Vaccine brands and eligibility changes

Re-instatement of prescription co-payment from today

 

 

Medinz: Reinstatement of prescription co-payment from 1 July 2024

From 1 July 2024, the standard $5 charge to collect prescribed medicine (the prescription co-payment) returns.

The co-payment will be waived for people:

  • aged 13 years or under

  • who hold a Community Services Card (CSC) or (a dependent child of a CSC holder)

  • aged 65 years and over, or

  • who hold a Prescription Subsidy Card (PSC)

Once a person or a family unit reaches 20 new prescription items in a year, they are eligible for a Prescription Subsidy Card. This means they will not have to pay any more prescription charges until 1 February the following year.

Some prescriptions will continue to attract a $15/$10 (adults/14-17 years) prescription co-payment, ie, from a private dentist or private specialist.

Pharmaceutical co-payment – Health New Zealand | Te Whatu Ora

COVID-19 Services Eligibility

 

Medinz: Important update on eligibility for COVID-19 Services and Funding from 1 July 2024

The COVID-19 service provision and funding model is changing.

  • Funded administration of COVID-19 vaccines will remain available for eligible people until 30 June 2025. From 30 Nov 2024 afterhours funding for vaccine delivery will cease. See here for more info.

  • COVID-19 antiviral medicines remain funded and available for eligible people at pharmacies. See here for eligibility criteria.

  • Free RATs for public distribution via community pharmacies continues until 30 September 2024.

  • Access to funded PPE will end 30 June 2024. 

  • A range of clinical telehealth services will no longer be available from 1 July. See attached PDF for further information

HealthPathways will be updated soon to reflect these changes.

Healthcare sector advisory - decommissioning of COVID-19 Clinical Telehealth Service 1.pdf

Vaccine Brands and Eligibility Changes

 

Medinz: Vaccine brands and eligibility changes from 1 July 2024

Please note the following changes from 1 July 2024 

Vaccine brand changes: 

  • Hib: The current vaccine, Hiberix, will be replaced with the Act-Hib vaccine. 

  • Varicella (chicken pox):  Varivax will be replaced with Varilrix vaccine. 

  • Hepatitis A adult: Brand name update from Havrix to Havrix 1440.

Vaccine change 

  • Meningococcal ACWY: The current MenC vaccine (Neisvac-C) funded for high-risk infants under 12 months will be replaced with MenACWY (Nimenrix).  Note: Neisvac-C should be discarded and not used after 1 July 2024.  

Change to eligibility 

  • Shingrix: vaccine funding will be widened to include immunocompromised people aged 18 years and over as per PHARMAC criteria, which can be found Updated information will be available on HealthPathways from 1 July.

For more information:

IMAC 18 Jun webinar - https://www.immune.org.nz/education/webinars

PDF Summary of vaccine changes from 1 July 2024.pdf

If you have any questions about these changes, please contact Auckland PHO’s Immunisation Coordinator - shanaz@aucklandpho.co.nz

Two new practices join Auckland PHO

 

We are pleased to welcome two new practices who join Auckland PHO today.  They are Teo Medical (formerly TL Care) in Te Atatū and Parnell Medical Centre.

 

Barbara Stevens | Tumu Whakarae/CEO


3 views0 comments

Recent Posts

See All

Comments


bottom of page